Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;24(6):451-458.
doi: 10.5005/jp-journals-10071-23465.

Protocolized Sedative Weaning vs Usual Care in Pediatric Critically Ill Patients: A Pilot Randomized Controlled Trial

Duangtip Tiacharoen  1 , Rojjanee Lertbunrian  2 , Jarin Veawpanich  2 , Nattanicha Suppalarkbunlue  3 , Nattachai Anantasit  2
Affiliations

Protocolized Sedative Weaning vs Usual Care in Pediatric Critically Ill Patients: A Pilot Randomized Controlled Trial

Duangtip Tiacharoen et al. Indian J Crit Care Med. 2020 Jun.

Abstract

Aims: The prolonged use of benzodiazepines and opioids can lead to an increase in the incidence of withdrawal syndrome. One of the known risk factors is the lack of a sedative-weaning protocol. This study established a sedative-weaning protocol and compared this protocol with the usual care of weaning in high-risk critically ill children.

Materials and methods: This was an open-label, randomized controlled trial in a tertiary-care hospital. We recruited children aged 1 month to 18 years who had received intravenous sedative or analgesic drugs for at least 5 days. The exclusion criteria were patients who had already experienced the withdrawal syndrome. We established a weaning protocol. Eligible patients were randomly divided into the protocolized (intervention) and usual care (control) groups. The primary objective was to determine the prevalence of the withdrawal syndrome compared between two groups.

Results: Thirty eligible patients were enrolled (19 in the intervention and 11 in the control group). Baseline characteristics were not significantly different between both the groups. The prevalence of the withdrawal syndrome was 84% and 81% of patients in the intervention and control group, respectively. The duration of the initial weaning phase was shorter in the intervention group than in the control group (p value = 0.026). The cumulative dose of morphine solution for rescue therapy in the intervention group was statistically lower than that in the control group (p value = 0.016).

Conclusion: The implementation of the sedative-weaning protocol led to a significant reduction in the percentage of withdrawal days and length of intensive care unit stay without any adverse drug reactions. External validation would be needed to validate this protocol.

Clinicaltrialsgov identifier: NCT03018977.

How to cite this article: Tiacharoen D, Lertbunrian R, Veawpanich J, Suppalarkbunlue N, Anantasit N. Protocolized Sedative Weaning vs Usual Care in Pediatric Critically Ill Patients: A Pilot Randomized Controlled Trial. Indian J Crit Care Med 2020;24(6):451-458.

Keywords: Benzodiazepine; Critically ill children; ICU sedation; Opioid; Weaning; Withdrawal syndrome.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

Figures

Flowchart 1
Flowchart 1
Protocol for intervention group: Initial phase. *Reduced doses 50% in patients who had renal or hepatic impairment
Flowchart 2
Flowchart 2
Protocol for intervention group: Tapering phase. *Reduced doses 50% in patients who had renal or hepatic impairment
Flowchart 3
Flowchart 3
Consolidated standards of reporting trials (CONSORT) diagram for the study. NPO, nothing per oral
Fig. 1
Fig. 1
The dosages of morphine solution during weaning period between the intervention and control group. *p value < 0.005
See this image and copyright information in PMC

References

    1. Katz R, Kelly HW, Hsi A. Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion. Crit Care Med. 1994;;22((5):):763––767.. doi: 10.1097/00003246-199405000-00009. DOI: - DOI - PubMed
    1. Franck LS, Naughton I, Winter I. Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients. Inten Crit Care Nurs. 2004;;20((6):):344––351.. doi: 10.1016/j.iccn.2004.07.008. DOI: - DOI - PubMed
    1. Ista E, van Dijk M, Gamel C, Tibboel D, de Hoog M. Withdrawal symptoms in critically ill children after long-term administration of sedatives and/or analgesics: a first evaluation. Crit Care Med. 2008;;36((8):):2427––2432.. doi: 10.1097/CCM.0b013e318181600d. DOI: - DOI - PubMed
    1. Best KM, Boullata JI, Curley MA. Risk factors associated with iatrogenic opioid and benzodiazepine withdrawal in critically ill pediatric patients: a systematic review and conceptual model. Pediatr Crit Care Med. 2015;;16((2):):175––183.. doi: 10.1097/PCC.0000000000000306. DOI: - DOI - PMC - PubMed
    1. Fonsmark L, Rasmussen YH, Carl P. Occurrence of withdrawal in critically ill sedated children. Crit Care Med. 1999;;27((1):):196––199.. doi: 10.1097/00003246-199901000-00052. DOI: - DOI - PubMed

Associated data

LinkOut - more resources